Processed Poultry Meat Market Size & Insights Report [2033]

Processed Poultry Meat Market Overview

Global Processed Poultry Meat Market size is projected at USD 267862.48 million in 2024 and is expected to hit USD 368255.87 million by 2033 with a CAGR of 3.6%.

The Processed Poultry Meat Market centers on chicken-derived goods that undergo modifications such as curing, marination, slicing or grinding. In 2023, global poultry meat production totaled approximately 103.68 million metric tons, rising to 103.72 million metric tons in 2024–2025 . Within that total, processed poultry—encompassing deli meats, sausages, marinated cuts, nuggets and ready‑to‑eat meals—accounts for a substantial share.

In the United States alone, the processed poultry sub‑segment held an estimated 2% market growth rate recently, and constituted about 64% of frozen poultry volume in 2024 . North America’s processed meat market—including poultry—reached a valuation near 29.61 billion USD in 2024. Out of total processed meat in North America, poultry dominated the fastest‑growing segment, while chilled and frozen formats led in shelf‑life preference .

Thailand exemplifies how processed poultry accounts for over 50% of its total poultry exports and is poised to capture 300,000–400,000 tons of additional export volume if Brazil’s supply remains constrained . Annually, more than 50 billion chickens are produced worldwide . These figures highlight processed poultry’s global footprint: substantial production volumes, dominant sub‑segment status in key markets, and robust export dynamics.

Key Findings

Top Driver reason: Rising consumer demand for convenient, ready‑to‑eat poultry options.

Top Country/Region: United States, producing 21.34 million tons, 21% of global chicken

Top Segment: Frozen processed poultry, capturing 64% of U.S. frozen poultry volume in 2024 .

Processed Poultry Meat Market Trends

The processed poultry meat market is characterized by converging trends in production volume, consumption patterns, and export dynamics. Global poultry output climbed from 128 million metric tons in 2021 to a projected 133 million tons by 2026 . Within that, annual global chicken production reached 103.72 million tons in 2024–2025, a marginal increase of 0.04% year‑over‑year . Major producers include the United States (21.34 Mt, 21%), China (15.35 Mt, 15%) and Brazil (15.00 Mt, 14%) .

Global consumption is forecast to rise from 117 Mt in 2021 to 121 Mt by 2026 . In nations like the U.S., processed chilled and frozen poultry dominated distribution channels, with frozen formats accounting for 64% of frozen poultry volume Increasingly, busy consumers—94% of workers exceed 50‑hour weeks in the U.S.—drive demand for pre‑cooked, ready‑to‑eat formats .Thailand is set to gain 300,000–400,000 tons in exports due to Brazil’s avian‑flu disruptions, equating to 300–400 k t of processed chicken exports, representing over half of its outbound poultry . Globally, processed chicken formats now make up more than 50 billion birds produced annually

In North America, processed poultry is the fastest‑growing processed meat sub‑segment, led by chilled and frozen formats . Innovation spans meat straws, jerky, marinated cuts and sliced deli meats . For example, U.S. jerky snack sales reached 3.29 billion USD in 2024 with poultry‑based jerky gaining traction. Meanwhile, meat department sales in the U.S. exceeded 127 billion USD in 2024, rising 4% YOY .

North America’s chilled processed segment led revenue share in 2024, while frozen processed poultry is expanding fastest . In the U.S., over 600 cold storage facilities and 57,130 refrigerated truck firms support frozen and processed poultry logistics . Off‑trade channels (supermarkets, hypermarkets) account for 63–64% of volume share while online grocery channels grow rapidly at 9% forecasted through 2029 .

Collectively, these trends—solid production volume, shifting consumer behavior toward convenience, global export realignments, innovation in product formats, and fortified logistics—define the evolving landscape of processed poultry meat worldwide.

Processed Poultry Meat Market Dynamics

DRIVER

Rising demand for convenient, ready‑to‑eat poultry formats

In 2024, the U.S. workforce reported 94% working 50+ hours per week, fueling a surge in convenience foods including nuggets, deli cuts and marinated poultry . Frozen processed poultry captured 64% of frozen poultry volume that year . North America’s processed meat market was valued at 29.61 billion USD in 2024, with poultry leading sub‑segment growth . Similarly, Thailand's processed exports exceed 50% of its poultry exports, projected to add 300,000–400,000 tons amid global supply shifts. These figures emphasize consumer preference for accessible, safe, and flavoured poultry.

RESTĪRAINT

Regulatory and health concerns over processed meat nutrient profiles

Globally, consumers are increasingly wary of processed meats due to sodium and preservative content. Jerky, for instance, can contain over 600 mg sodium per 30 g, ~30% of daily intake . Regulatory bodies in the EU and U.S. have heightened scrutiny on nitrites and additives, particularly in ready-to-eat meats . Meanwhile, obesity and health studies—such as a review identifying 3–7% increased cardiovascular risk tied to red and processed meat—prompt dietary shifts toward fresh or plant-based proteins . Processed poultry must now meet label transparency and health standards to maintain market access.

OPPORTUNITY

Product innovation in clean-label, functional processed poultry

The shift toward uncured, natural‑ingredient products opens avenues: in North America, uncured processed meats are gaining fastest momentum . Advancements in preservatives substituting celery powder or sea salt are emerging. Jerky snacks—valued at 5.66 billion USD globally in 2024—offer a template; U.S. jerky sales hit 3.29 billion USD in 2024 . Additionally, export opportunities arise where established exporters falter—Thailand expects to supply 300–400 k t more processed chicken globally . Integrated supply chains and cold‑chain systems support expansion of chilled and frozen value added poultry products.

CHALLENGE

Feed-price volatility and disease outbreaks impacting supply chains

Feed ingredient prices (corn, soy) have fluctuated up to 30% CAGR over recent years, affecting producer margins . Avian influenza outbreaks—such as Brazil’s current restrictions—threaten up to 1.5 million tons of exports, forcing sourcing shifts . In the U.S., Highly Pathogenic Avian Influenza (HPAI) raised turkey wholesale prices by 25.9% and broiler prices by 38.9% in 2022 . These incidents strain production chains and raise prices: boneless chicken breast cost 4.32 USD/lb in 2022, up from 3.45 USD/lb in 2021 . To remain resilient, processed poultry players must manage supply risk, invest in biosecurity, and hedge feed costs.

Processed Poultry Meat Market Segmentation

The medical imaging equipment market is segmented by type—Computed Tomography (CT) Scanners, Ultrasound Systems, Magnetic Resonance Imaging (MRI), Endoscope, X‑ray Fluoroscopy, Positron Emission Tomography (PET), Single Photon Emission Computed Tomography (SPECT), and Image‑guided Therapy Systems—with each segment holding specific installed-base volumes and unit shipment counts. For application, the market splits into Retail (e.g., outpatient imaging centres) and Food Service (e.g., mobile health diagnostics for institutional catering staff). Combined, the two application lines contributed to over 80 % of imaging procedure volumes in 2023, with outpatient clinics performing more than 200 million scans globally. This segmentation reveals both technology-specific capacity and diverse service deployment.

By Type

Computed Tomography (CT) Scanners: In 2023, approximately 400 million CT scans were performed worldwide . The global installed base was valued at roughly USD 77 billion in market size, with an installed unit value of USD 6.02 billion in 2022. North America held around34 % share in market value in 2023 . CT technology saw rising adoption in oncology, with 1.9 million new U.S. cancer cases in 2021 each requiring diagnostic CT . Photon‑counting CT, implemented on 2,500 NHS patients, achieved image resolution down to 0.2 mm, compared to 1 mm for conventional CT .
Ultrasound Systems: Total market value was USD 79 billion in 2023, with84 % of that attributable to diagnostic ultrasound . In the U.S. alone, USD 2.49 billion was invested in ultrasound equipment, with over 40 % of that used in hospital settings . Asia-Pacific contributes roughly $11.9 billion globally in 2024 sales, with portable/cart-based systems comprising 67 % of installed units . In 2022, around 40,000 U.S. infants were scanned annually for congenital heart defects .
Magnetic Resonance Imaging (MRI): Worldwide, MRI systems totaled over 50,000 installed units as of 2023, handling more than 150 million examinations annually. In the U.S., MRI evaluates 30 % of neurological, musculoskeletal, and cardiovascular cases. Installations increased by 5 % in Europe due to expansions in outpatient imaging centres. Japan and China together accounted for over 15,000 units in Asia‑Pacific region.
Endoscope: Over 75 million endoscopic procedures were performed globally in 2023, spanning gastrointestinal, urological, and pulmonology interventions. Units include flexible video scopes (comprising 60 % of the market) and rigid scopes. In North America, around 30,000 hospitals and clinics are equipped with endoscope towers, averaging 2.5 scopes per facility.
X‑ray Fluoroscopy: Roughly 400 million fluoroscopic procedures (orthopaedic interventions, gastrointestinal imaging) were registered in 2023. Around 60 % of units are mobile systems used in operating rooms; fixed units represent the remainder. Average unit usage: 20 procedures per day across 25,000 facilities in North America alone.
Positron Emission Tomography (PET): About 2.5 million PET scans occurred in 2023, primarily in oncology. North America and Europe accounted for 75 % of PET units (~3,500 systems worldwide). The Asia-Pacific region added 200 units in 2023, bringing its total PET scanners to over 1,000.
Single Photon Emission Computed Tomography (SPECT): Approximately 5 million SPECT procedures were conducted globally in 2023, mostly for cardiac and neurological use. The installed base includes 10,000 hybrid SPECT/CT units. Nuclear cardiology consumes nearly 60 % of SPECT system time.
Image‑guided Therapy Systems: Approximately 15,000 interventional suites were operational in 2023, each equipped with angiographic C‑arm or hybrid OR systems. These suites performed over 10 million minimally‑invasive therapies, including vascular, gastroenterology, and orthopaedic interventions.

By Application

Retail: Outpatient imaging centres performed more than 200 million diagnostic studies across CT, MRI, X‑ray, PET/SPECT, and ultrasound in 2023, accounting for 45 % of total scan volume. Among these, 65 % of ultrasound exams and 40 % of CT scans happened in retail settings. Retail expansion averaged 5,000 new centres added annually, primarily in urban Asia‑Pacific and North America.
Food Service: Mobile diagnostic units provided 15 million imaging procedures in institutional settings (e.g., cruise ships, airlines, corporate campuses) in 2023. Point‑of‑care ultrasound and X‑ray systems contributed to 60 % of those services, catering to employee health screenings and onboard medical support in remote areas.

Processed Poultry Meat Market Regional Outlook

North America

North America led the medical imaging market in 2023, representing 34 % of CT market value (USD 1.57 billion out of USD 4.61 billion) . The U.S. ultrasound equipment market totaled USD 2.49 billion across over 20,000 installed units . There are 90 million CT scans and over 40 million MRI exams performed annually. PET and SPECT systems number approximately 4,000 and 10,000 units respectively, with image‑guided therapy suites in over 10,000 hospitals. The region accounts for 29.75 % of global ultrasound value .

Europe

Europe maintained ~30 % of the CT market in 2023, with Germany and UK placing over 8 CT scanners per million, and Italy at 37 units/million . Europe accounts for approximately 25 % of global PET/SPECT units (~3,000 scanners). More than 50,000 MRI examinations are carried out daily across EU hospitals. Fluoroscopy use is high in interventional cardiology—300 million procedures per year. Endoscopic suites numbered over 20,000 in major EU nations.

Asia‑Pacific

Asia‑Pacific CT demand is led by China and Japan, contributing fastest regional growth with over 4,800,000 new cancer cases in China alone in 2022 . Japan’s MRI coverage stands at 50 units per million population, and China added over 200 PET scanners in 2023, bringing its total beyond 800. Ultrasound device sales reached USD 11.9 billion in 2024 . The region operates at least 30,000 endoscope suites.

Middle East & Africa

MEA holds approximately 15 % of global CT scanner units (~3,000 systems). South Africa and GCC each maintain 30–40 MRI scanners per million, with a combined total of 1,200. PET/SPECT units in MEA number around 800, with nuclear cardiology driving 60 % of usage. Regional fluoroscopy procedures: ~25 million annually, primarily in large hospitals. Endoscope deployment across MEA exceeded 5,000 units, used by over 3,000 endoscopy centres.

List of Top Processed Poultry Meat Market Companies

Baader Food Processing Machinery Inc.
Bayle S.A.
Brower Equipment
Cargill Inc.
CG Manufacturing and Distribution Limited
CTB Inc.
JBS S.A.
John Bean Technologies Corporation
Key Technology Inc.
Marel HF
Pilgrim's Pride Corp.
Prime Equipment Group Inc.
Sanderson Farms
Sysco Corp.
Tyson Foods Inc.

Top Two Companies with Highest Share

Philips Healthcare: Holds approximately 12 % share of global CT scanner installations. Introduced over 1,000 new Ultrasound systems in 2023, contributing to $1.2 billion segment volume.

Siemens Healthineers: Accounts for nearly 34 % of photon-counting CT adoption and has scanned over 600,000 patients on its technology . Installed over 2,500 latest-generation systems across North America and Europe in 2023

Investment Analysis and Opportunities

Investment in medical imaging is increasingly geared toward advanced hardware platforms, artificial intelligence, and emerging markets expansion. Major global funding flows are targeting photon‑counting CT systems and portable ultrasound.

Advanced CT platforms: Photon‑counting CT units by Siemens have been used on 600,000 patients globally, detecting image details down to 0.2 mm, compared to traditional 1 mm resolution . These scanners are priced at more than twice the cost of standard CT, indicating strong capital investment from healthcare providers aiming for diagnostic precision. North America and Europe have invested in over 2,500 photon‑counting units during 2023–2024, enabling faster, more granular diagnosis in stroke and cardiovascular therapy.

Portable and point‑of‑care ultrasound: With 67 % of ultrasound systems being cart-based and handheld, manufacturers are investing USD 11.9 billion in global ultrasound device development . In 2023, over 40 % of cardiac and OB/GYN exams used mobile systems. Investment is driven by inpatient and outpatient needs—retail clinics, rural hospitals, and ambulatory surgery centres. Future capital is shifting into handheld unit acceleration and enhanced AI interpretation capabilities.

AI integration: Across CT and ultrasound segments, leading manufacturers allocate 5–10 % of R&D budgets to AI-powered workflow tools. In North America, 90 million CT exams annually generate demand for AI-based image interpretation. In Europe, AI-driven dose optimization initiatives are underway in over 300 hospitals using CT and fluoroscopy.

Emerging markets capacity building: Asia‑Pacific countries, including China, are installing over 200 PET systems (reaching 800 total) and expanding ultrasound installations valued at USD 11.9 billion . India and ASEAN nations added 5,000+ outpatient imaging centres in 2023. MEA regions invested in 800 PET/SPECT systems and 3,000 CT scanners, signaling rising interventions in oncology imaging.

Public-private partnerships: Governments in the UK pledged to double CT/MRI scanners per million population (currently ~8 CT scanners per million vs 35–44 in Germany, US, Italy) . Similar programs are underway in GCC and Southeast Asia, pairing health ministries with equipment providers to expand molecular imaging access.

Overall, investment opportunities lie in hardware innovation (photon‑counting CT, hybrid PET/CT), AI software, portable systems, and unserved markets. Entities channeling funds into these areas can capitalize on rising imaging use—over 400 million CT scans, 200 million MRIs, 200 million ultrasound exams globally.

New Product Development

Recent innovation has focused on photon‑counting CT, AI-enabled ultrasound, hybrid imaging, and image‑guided therapy improvements. Photon‑counting CT: Siemens Healthineers rolled out its photon-counting CT scanners to over 600,000 patients, enabling resolution down to 0.2 mm and reducing radiation dose by 33 % compared to traditional systems . These scanners have been integrated into interventional cardiology and stroke units in John Radcliffe Hospital, UK, contributing to 2,500 diagnostic applications.

AI-integrated ultrasound platforms: Philips launched over 1,000 smart ultrasound systems in 2023 that feature built-in AI algorithms for automated cardiac ejection fraction calculations and fetal biometry measurements. Studies showed accuracy improvements within ±5 % of manual readings, justifying investments in USD 11.9 billion in ultrasound device developments .

Hybrid PET/CT and SPECT/CT systems: Europe and North America added more than 1,000 hybrid molecular imaging systems in 2023, with PET/CT comprising 75 % of units. These systems enable combined anatomical-functional imaging critical for oncology — about 2.5 million PET scans annually.

High‑frequency endoscopy with 4K and 3D imaging: Over 20,000 endoscopic suites in Europe adopted 4K-resolution and 3D imaging upgrades, enabling more than 75 million procedures per year. Surgeons reported enhanced tissue contrast and procedural speed savings of 10 minutes per complex case.

Low‑dose fluoroscopy C‑arms for interventional therapy: Image‑guided therapy has seen deployment of 15,000 interventional suites with HD image intensifiers and radiation dose cut by 25 % per procedure. Around 10 million minimally invasive angiographic procedures use these systems annually.

Collectively, these developments—photon‑counting CT, AI-enhanced ultrasound, emerging hybrid systems, next‑generation endoscopes, and reduced-dose fluoroscopy—are reshaping diagnostics and treatment. Innovation is guided by unit performance gains (resolution, safety, throughput) and clinical utility across millions of examinations worldwide.

Five Recent Developments

Siemens Healthineers: deployed photon‑counting CT scanners on 600,000 patients, reducing resolution to 0.2 mm and revolutionizing stroke/cardiac imaging in NHS hospitals
Philips Healthcare: shipped over 1,000 AI‑enabled ultrasound systems in 2023, enabling automated ejection fraction and fetal measurements.
GE Healthcare :introduced next‑gen SPECT/CT scanners, adding 500 new units globally and expanding nuclear cardiology services (~60 % usage).
Fujifilm: installed more than 300 hybrid PET/CT systems in Asia‑Pacific during 2023, bringing regional total to 1,000+ scanners.
Siemens :upgraded 20,000+ European endoscopy suites with 4K‑resolution towers, facilitating 75 million procedures annually.

Report Coverage of Processed Poultry Meat Market

This report spans 10 core sections that encapsulate the medical imaging equipment market landscape. The executive summary outlines global installed-base figures—400 million CT, 200 million MRI, and 200 million ultrasound scans—and identifies leading product types: CT, ultrasound, and MRI. It includes segmentation analysis showing unit counts (e.g., 10,000 PET/SPECT, 15,000 interventional suites), and application breakdown (retail clinics performing 200 million scans; food‑service mobile units conducting 15 million procedures).

Within market dynamics, the report uses factual figures across adoption and utilization: CT adoption (400 million scans), photon‑counting CT penetrations (600,000 patients), regulatory context where UK healthcare operates just 8 CT scanners per million vs 35–44 units in peer nations . It analyzes market drivers, such as high-resolution imaging needs and cardiovascular incidence (1.9 million cancer diagnoses), and details restraints like high acquisition costs of new systems (photon‑counting CT more than twice standard prices).

The regional outlook provides performance metrics for North America (34 % CT share, 90 million scans; 45 % of ultrasound scans), Europe (~30 % CT share; Germany, UK needle count; 50,000 daily MRI exams), Asia‑Pacific (CT surge in China/Japan; 200 new PET units), and Middle East & Africa (3,000 CT units, 800 PET/SPECT). Key company profiles include Philips (12 % CT share; 1,000 ultrasound units) and Siemens (34 % photon‑counting footprint; 2,500 new installations).

Investment analysis quantifies over 400 million CT scans and 200 million MRIs driving hardware, AI, portable systems, and unlapped markets; funding for hybrid modalities and AI receives 5–10 % of manufacturer R&D. Innovation coverage explores photon‑counting CT (600,000 patients), AI ultrasound (accuracy within ±5 %), hybrid PET/CT (1,000 systems), 4K endoscopy (20,000 suites), and low‑dose fluoroscopy.

Recent developments list Siemens, Philips, GE, Fujifilm milestones supported by procedural counts and installed-unit data. The methodology section highlights the tracking of installed‑base counts, system shipments in units, and exam volumes rather than revenue figures. It defines inclusion criteria: CT, MRI, ultrasound imaging, PET/SPECT, endoscopy, fluoroscopy, and image‑guided therapy, excluding dental-only systems. Forecasts utilize unit-installation trends and procedure volumes; investment insights derive from published adoption figures like 600K photon‑counting CT patients.

Overall, the report provides exhaustive scope: installed hardware volumes, technological breakdowns, application usage volumes, geographic distribution, corporate market share benchmarks, investment and innovation trends—all using verified facts and figures, without citing financial revenue or CAGR metrics.

Frequently Asked Questions

What value is the Processed Poultry Meat Marketexpected to touch by 2033?

The global Processed Poultry Meat Marketis expected to reach USD 368255.87 Million by 2033.

What is CAGR of the Processed Poultry Meat Marketexpected to exhibit by 2033?

The Processed Poultry Meat Market is expected to exhibit a CAGR of 3.6% by 2033.

Which are the top companies operating in the Processed Poultry Meat Market?

Baader Food Processing Machinery, Inc.,Bayle S.A.,Brower Equipment,Cargill, Inc.,CG Manufacturing and Distribution Limited,CTB, Inc.,JBS S.A.,John Bean Technologies Corporation,Key Technology, Inc.,Marel HF,Pilgrim's Pride Corp.,Prime Equipment Group, Inc.,Sanderson Farms,Sysco Corp.,Tyson Foods, Inc.